SCHEMBL4900151

SCHEMBL4900151

C[C@H](Nc1c(NCc2ccc3[nH]cnc3c2)c(=O)c1=O)c1cccc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 10/20 0.47
HDAC1 Q13547 3/20 0.38
OPRK1 P41145 1/20 0.36
CDK1 P06493 3/20 0.36
CCNB2 O95067 2/20 0.36
CCNB1 P14635 2/20 0.36
CCNB3 Q8WWL7 2/20 0.36
PFKFB3 Q16875 1/20 0.34
PLK4 O00444 1/20 0.34
CHEK1 O14757 1/20 0.34
DAPK3 O43293 1/20 0.34
DYRK3 O43781 1/20 0.34
JAK2 O60674 1/20 0.34
ROCK2 O75116 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
CHEK2 O96017 1/20 0.34
PRKCG P05129 1/20 0.34
ROS1 P08922 1/20 0.34
PIM1 P11309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907742 1.00 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4898767 0.88 RPS6KB1 (0.40) CDK1CCNB2CCNB1CCNB3PLK4
SCHEMBL4900221 0.84 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4897972 0.84 MAPKAPK2 (0.47) MAPKAPK2HDAC1OPRK1CDK1CCNB2
SCHEMBL4598811 0.83 MAPKAPK2 (0.61) MAPKAPK2ROCK2CHEK2MAPK1GSK3B
SCHEMBL4596962 0.83 MAPKAPK2 (0.61) MAPKAPK2ROCK2CHEK2MAPK1GSK3B
SCHEMBL4598401 0.79 KDR (0.47) RPS6KB1KDRAURKB
SCHEMBL4905587 0.79 ROCK1 (0.48) MAPKAPK2CDK1PLK4CHEK1DAPK3
SCHEMBL4598110 0.74 MAPKAPK2 (0.49) MAPKAPK2MAPK1ROCK1AURKBCYP2C9
SCHEMBL4905562 0.74 KDR (0.44) MAPKAPK2CDK1CCNB2CCNB1CCNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 MAPKAPK2 346/4885HDAC1 1193/4885OPRK1 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.